시장보고서

상품코드

2019933

단백질 정제 및 분리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Protein Purification And Isolation Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: 2026년 03월 | 리서치사: 구분자

Value Market Research | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

가격

PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 발췌나 도표 복사는 Value Market Research를 인용하여야 하며, 사내용 문서에 한해 가능합니다. 인쇄는 가능하지만, 인쇄물은 구매한 조직 내에서만 보관해야 합니다. 또한, 보고서 내용을 AI 도구나 자동 분석 플랫폼에 업로드하거나, 외부 공개 및 상업적 이용은 금지되어 있습니다.

US $ 3,920

￦ 5,438,000

PDF & Excel (10-user License)

PDF & Excel 보고서를 동일 기업내 10명까지 이용할 수 있는 라이선스입니다. 텍스트 발췌나 도표 복사는 Value Market Research를 인용하여야 하며, 사내용 문서에 한해 가능합니다. 인쇄는 가능하지만, 인쇄물은 구매한 조직 내에서만 보관해야 합니다. 또한, 보고서 내용을 AI 도구나 자동 분석 플랫폼에 업로드하거나, 외부 공개 및 상업적 이용은 금지되어 있습니다.

US $ 4,730

￦ 6,561,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다.

US $ 7,430

￦ 10,307,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

단백질 정제 및 분리 시장 규모는 2025년 112억 1,000만 달러에서 2026년부터 2034년까지 CAGR 11.17%로 성장하여 2034년에는 290억 6,000만 달러에 달할 것으로 예측됩니다.

세계 단백질 정제 및 분리 시장은 단백질체학 및 생명공학 분야의 연구개발 증가에 힘입어 견조한 성장세를 보이고 있습니다. 특히 종양학 및 희귀질환의 표적치료에 대한 수요가 증가함에 따라 정제된 단백질의 필요성이 크게 증가하고 있습니다. 제약 및 바이오 제약 기업은 고품질 의약품의 개발 및 제조를 보장하기 위해 첨단 정제 기술에 많은 투자를 하고 있습니다.

주요 촉진요인으로는 크로마토그래피, 전기영동, 여과 기술 등 효율성과 정확성을 향상시키는 기술 발전을 들 수 있습니다. 학술 연구 활성화, 바이오의약품 파이프라인 확대, 생명과학 연구에 대한 정부 자금 지원 증가도 시장 성장에 기여하고 있습니다. 또한, 맞춤형 의료의 부상으로 고순도 단백질에 대한 강력한 수요가 발생하고 있습니다.

향후 정제 워크플로우의 자동화와 AI의 통합이 시장을 변화시킬 것으로 예상됩니다. 연속 처리 기술과 확장성 향상으로 생산성이 향상될 것입니다. 신흥 시장에서는 연구 인프라의 확충과 함께 도입이 확대될 것으로 예상되며, 정제 방법의 혁신은 보다 신속하고 비용 효율적인 의약품 개발을 뒷받침할 것입니다.

The global protein purification and isolation market is witnessing robust growth driven by increasing research in proteomics and biotechnology. The rising demand for targeted therapies, especially in oncology and rare diseases, has significantly boosted the need for purified proteins. Pharmaceutical and biopharmaceutical companies are investing heavily in advanced purification techniques to ensure high-quality drug development and production.

Key drivers include technological advancements such as chromatography, electrophoresis, and filtration techniques that enhance efficiency and accuracy. Growing academic research, expanding biopharma pipelines, and increasing government funding for life sciences research are also contributing to market growth. Additionally, the rise of personalized medicine is creating strong demand for high-purity proteins.

In the future, automation and integration of AI in purification workflows are expected to transform the market. Continuous processing technologies and improved scalability will enhance productivity. Emerging markets are likely to see increased adoption due to expanding research infrastructure, while innovations in purification methods will support faster and more cost-effective drug development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

Instruments
Consumables
Kits
Reagents
Columns
Magnetic Beads
Resins
Others

By Technology

Ultrafiltration
Precipitation
Chromatography
Ion Exchange Chromatography
Affinity Chromatography
Reversed-Phase Chromatography
Size Exclusion Chromatography
Hydrophobic Interaction Chromatography
Electrophoresis
Gel Electrophoresis
Isoelectric Focusing
Capillary Electrophoresis
Western Blotting
Others

By Application

Drug Screening
Biomarker Discovery
Protein-protein Interaction Studies
Diagnostics

By End Use

Academic and Research Institutes
Hospitals
Pharmaceutical and Biotechnological Companies
CROS

COMPANIES PROFILED

Thermo Fisher Scientific Inc, Merck KGaA, BioRad Laboratories Inc, GE Healthcare Cytiva, Agilent Technologies Inc, Qiagen NV, Promega Corporation, Takara Bio Inc, Abcam plc, Danaher
We can customise the report as per your requirements.

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET: BY PRODUCT 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product
4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Columns Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.7. Magnetic Beads Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.8. Resins Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Technology
5.2. Ultrafiltration Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Precipitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Ion Exchange Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Affinity Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.7. Reversed-Phase Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.8. Size Exclusion Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.9. Hydrophobic Interaction Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.10. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.11. Gel Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.12. Isoelectric Focusing Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.13. Capillary Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.14. Western Blotting Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.15. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET: BY APPLICATION 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Application
6.2. Drug Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Protein-protein Interaction Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET: BY END USE 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End Use
7.2. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Pharmaceutical and Biotechnological Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. CROS Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET: BY REGION 2022-2034 (USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Technology
- 8.2.3 By Application
- 8.2.4 By End Use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Technology
- 8.3.3 By Application
- 8.3.4 By End Use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Technology
- 8.4.3 By Application
- 8.4.4 By End Use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Technology
- 8.5.3 By Application
- 8.5.4 By End Use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Technology
- 8.6.3 By Application
- 8.6.4 By End Use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PROTEIN PURIFICATION AND ISOLATION INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific Inc
- 10.2.2 Merck KGaA
- 10.2.3 Bio-Rad Laboratories Inc
- 10.2.4 GE Healthcare (Cytiva)
- 10.2.5 Agilent Technologies Inc
- 10.2.6 Qiagen N.V
- 10.2.7 Promega Corporation
- 10.2.8 Takara Bio Inc
- 10.2.9 Abcam Plc
- 10.2.10 Danaher

단백질 정제 및 분리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Protein Purification And Isolation Market Size, Share, Trends & Growth Analysis Report 2026-2034

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 단백질 정제 및 분리 시장 : 제품별

제5장 세계의 단백질 정제 및 분리 시장 : 기술별

제6장 세계의 단백질 정제 및 분리 시장 : 용도별

제7장 세계의 단백질 정제 및 분리 시장 : 최종사용별

제8장 세계의 단백질 정제 및 분리 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape: